Jinglong Huang

3PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 30, 2025
Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs.

Caifeng Gong, Jinglong Huang, Dandan Cao

|Nov 18, 2024
Regorafenib monotherapy as the later-line treatment for elderly patients with metastatic colorectal cancer: a multicenter real-world study.

Jinglong Huang, Caifeng Gong, Zhichao Jiang

|Oct 16, 2023
Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors.

Jinglong Huang, Caifeng Gong, Aiping Zhou

Pageof 1